Faster method to create antibodies for disease research British scientists are pioneering a new technique to produce large numbers of antibodies quickly and reliably to help the study of dangerous bacteria. The research, funded by the Biotechnology and Biological Sciences Research Council (BBSRC), is a critical area for study as bacteria such as streptococcus cause deadly blood infections and ‘flesh eating bug disease’. Traditional methods of producing antibodies for research are slow and laborious and pose a significant bottleneck to proteomics research as they can take months of effort. This research offers a potential solution that could produce antibodies in just weeks. Antibodies are vital to the study of proteins as they can bind specifically to a protein of interest and enable researchers to identify, count and track the protein in vitro and in vivo. The study of proteins is important to almost every area of biology as they are often the targets for vaccines, the raw materials for bioprocessing or are employed as environmental biomarkers. The researchers from Imperial College London at Hammersmith Hospital discovered that a large proportion of antibodies created in response to synthetic peptide immunisation bind to the end of a peptide known as the C-terminus. The unique way that it is presented means that the antibodies will only bind to proteins that contain a precise sequence in their C-terminus.
